About the journal
Therapeutic Advances in Medical Oncology is an open-access journal published by SAGE Publishing in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,800 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- SAGE Publishing
- ISSN
- 1758-8340 · 1758-8359
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,800 USD
- Articles in DOAJ
- 1950
- Declared review time
- 15 weeks
- Declared peer-review model
- peer_review
- Official website
- https://journals.sagepub.com/home/tam
Index listings
- DOAJ · 2018-04-04
- Indexing
- DOAJ
- APC
- 2,800 USD
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
1950
Most recent article
last month
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
1904
Last recorded publication year
2026
h-index
90
i10-index
933
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-04
- Added to DOAJ
- 2018-04-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPorticoScholars Portal
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 96%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- Medical oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 101510808
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
Show all subjects (50)
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Advanced Breast Cancer Therapies
- Advanced Breast Cancer Therapies
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Esophageal Cancer Research and Treatment
- Neuroendocrine Tumor Research Advances
- Neuroendocrine Tumor Research Advances
- Esophageal Cancer Research and Treatment
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Head and Neck Cancer Studies
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Head and Neck Cancer Studies
- Inflammatory Biomarkers in Disease Prognosis
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Genetic factors in colorectal cancer
- Genetic factors in colorectal cancer
Keywords (DOAJ)
- oncology
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ